Hybrid model of erythropoiesis and leukemia treatment with cytosine arabinoside

DOI10.1137/100815517MaRDI QIDQ3225271zbMATH OpenOpenAlexWikidataFDO

Authors P. Kurbatova, Samuel Bernard, N. Bessonov, Fabien Crauste, I. Demin, Charles Dumontet, Stephan Fischer, Vitaly Volpert

Publication date 16 March 2012

Published in SIAM Journal on Applied Mathematics (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1137/100815517

zbMATH Keywords

cell cycleregulatory networkschronotherapy

Mathematics Subject Classification ID

Medical applications (general) (92C50) Probabilistic models, generic numerical methods in probability and statistics (65C20) PDEs in connection with biology, chemistry and other natural sciences (35Q92) Biological rhythms and synchronization (92B25) Cell biology (92C37) Kinetics in biochemical problems (pharmacokinetics, enzyme kinetics, etc.) (92C45)

Recommendations

• Dynamics of Erythroid Progenitors and Erythroleukemia
• Hybrid models in erythropoiesis and in megakaryopoiesis
• Hybrid mathematical model of leukemic diseases
• A multi-agent model describing self-renewal of differentiation effects on the blood cell population
• A control delay differential equations model of evolution of normal and leukemic cell populations under treatment

Cited in

(6)

• Blood cell dynamics: half of a century of modelling
• Discrete and continuum models for the evolutionary and spatial dynamics of cancer: a very short introduction through two case studies
• The role of spatial organization of cells in erythropoiesis
• Hybrid models in erythropoiesis and in megakaryopoiesis
• Mathematical models of leukaemia and its treatment: a review
• Discrete and continuum phenotype-structured models for the evolution of cancer cell populations under chemotherapy

This page was built for publication: Hybrid model of erythropoiesis and leukemia treatment with cytosine arabinoside

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3225271)